Profile
Hubert Köster was the founder of Sequenom, Inc. (founded in 1996) where he held the titles of President, Chief Executive Officer & Director until 2000, and caprotec bioanalytics GmbH (founded in 2007) where he held the title of Managing Director & Chief Scientific Officer.
He also worked as a Professor at Boston University.
Köster graduated from the University of Hamburg with a graduate degree and earned doctorates from both the Max-Planck-Institute for Molecular Genetics and the Max Planck Institut für experimentelle Medizin.
Former positions of Hubert Köster
| Companies | Position | End |
|---|---|---|
| SEQUENOM, INC. | Founder | 2000-04-30 |
caprotec bioanalytics GmbH
 caprotec bioanalytics GmbH BiotechnologyHealth Technology caprotec bioanalytics GmbH commercializes Capture Compound Mass Spectrometry technology. It offers compound profiling services, supplies managing risk services, support the development of the health market and biomarker, rescues projects, selects and optimizes the development processes, and offers collaborations with other companies. The company was founded by Hubert Koester in 2007 and is headquartered in Berlin, Germany. | Chief Executive Officer | - |
| Boston University | Corporate Officer/Principal | - |
Training of Hubert Köster
| University of Hamburg | Graduate Degree |
| Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
| Max Planck Institut für experimentelle Medizin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
caprotec bioanalytics GmbH
caprotec bioanalytics GmbH BiotechnologyHealth Technology caprotec bioanalytics GmbH commercializes Capture Compound Mass Spectrometry technology. It offers compound profiling services, supplies managing risk services, support the development of the health market and biomarker, rescues projects, selects and optimizes the development processes, and offers collaborations with other companies. The company was founded by Hubert Koester in 2007 and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Hubert Köster
